Active Implants' NUsurface Meniscus Implant Starting IDE Clinical Trial
Executive Summary
Active Implant LLC is targeting the $1.5 billion annual global market for a meniscus replacement device with its NUsurface Meniscus Implant, and is starting an IDE clinical trial in the US.